Avera Names Myles Greenberg, MD, as CEO of Alucent Medical
“NVS Therapy has the potential to dramatically improve the care of patients suffering from debilitating peripheral vascular disease, and I look forward to being a part of the team advancing this groundbreaking technology into patient treatment,” Dr....
